$31.57
Price
$5.0B
Market Cap
11.4
P/E Ratio
17.8
Forward P/E
$2.77
EPS (TTM)
—
Dividend Yield
$132M
Cash
$254M
Total Debt
159M
Shares Out
$25.28
$46.48
52-Week Range
Institutional Ownership of TG THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for TG THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| SELL | EXIT | — | — | $32.38 | |
| 2025-Q2 | |||||
| BUY | NEW | 14.8K | $531500 | $36.72 | |
Insider Trading for TG THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $835K
0
Buys
2
Sells
-835K
Net
4
Grants
Largest
$672K
Lonial
$163K
Echelard
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 08, 2026 | Michael S Weiss | CEO | GRANT | 622.0K | — | — |
| Jan 08, 2026 | Sean A Power | CFO | GRANT | 90.0K | — | — |
| Nov 24, 2025 | Yann Echelard | Director | SELL | 5.0K | $32.57 | $163K |
| Nov 05, 2025 | Michael S Weiss | CEO | GRANT | 803.7K | — | — |
| Nov 05, 2025 | Michael S Weiss | CEO | GRANT | 3.87M | — | — |
| Sep 11, 2025 | Sagar Lonial | Director | SELL | 20.9K | $32.24 | $672K |